Springfield, FL, United States of America

Carl L Faingold


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Emeryville, CA (US) (2019)
  • Springfield, FL (US) (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carl L. Faingold

Introduction

Carl L. Faingold is a notable inventor based in Springfield, Florida. He has made significant contributions to the field of medicine, particularly in the treatment of respiratory depression. With a total of two patents to his name, Faingold's work focuses on innovative methods that address critical health issues.

Latest Patents

Faingold's latest patents include compositions and methods for treating respiratory depression using fenfluramine, a 5-HT receptor agonist. These methods are designed to treat and reduce the occurrence of respiratory depression caused by opioids in patients. The patents detail how administering a 5-HT4 agonist, such as fenfluramine, can stimulate specific receptors in the brain of patients at risk of respiratory depression. Additionally, pharmaceutical compositions for practicing these methods are also provided.

Career Highlights

Carl L. Faingold is associated with Zogenix International Limited, where he continues to develop and refine his innovative approaches to medical treatment. His work has the potential to significantly impact patient care and improve outcomes for those suffering from respiratory issues related to opioid use.

Collaborations

Faingold has collaborated with notable colleagues, including Bradley S. Galer and Parthena Martin, to advance his research and innovations in the medical field.

Conclusion

Carl L. Faingold's contributions to the treatment of respiratory depression highlight the importance of innovation in medicine. His patents and ongoing work at Zogenix International Limited demonstrate a commitment to improving patient health and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…